Since March 4, six spine and orthopedic devicemakers announced leadership moves.
Spinal Tech
The FDA granted 16 orthopedic device approvals in February:
Spine and orthopedic medtech companies are drawing the eyes and dollars of investors in 2022. Five companies have netted a total $123.6 million in deals so far.
Augmedics, developer of the Xvision augmented reality spine surgery system, began 2022 with a new CEO and recently added former Medtronic and Johnson & Johnson executives to its leadership team to help take the company to the next level.
Surgalign Holdings' global revenue for the fourth quarter decreased 16.8 percent year over year to $21.8 million as COVID-19 headwinds such as hospital staff shortages and procedural restrictions continued to affect surgical specialties.
Advertisement
Physiatrists — or physical medicine and rehabilitation physicians — collaborate with spine surgeons to develop personalized treatment plans for patients before and after surgery to optimize outcomes.
SeaSpine's 2021 revenue boost and three more updates from spine device companies in the last week:
Devicemaker 3Spine landed a $33 million series C investment round to support clinical trials of its lower back total joint replacement device.
Augmedics added former DePuy Synthes President Nadav Tomer to the board of directors and former Medtronic executive Reed Krider as chief marketing officer.
Intraoperative neuromonitoring company Assure Holdings saw a leap in managed case volume in 2021, according to fourth-quarter and full-year results posted March 14.